Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...

Artedrone is developing a microrobot system that can navigate to blood clots for autonomous mechanical thrombectomies.

OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...

Shares of NeurAxis, Inc. NRXS have gained 13.3% since the company reported its earnings for the quarter ended March 31, 2025.

Q1 2025 Earnings Call Transcript May 11, 2025 Operator: Greetings, and welcome to KORU Medical Systems First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

I can't comment on any particular application. As you know, we have a bunch of applications for those booster shots," FDA Commissioner Dr. Marty Makary told CBS News chief Washington correspondent ...

Insulet has shown impressive revenue and profit growth, driven by its Omnipod System and expanding global presence. Read more ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.

"I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth," the FDA's Commissioner of Food and Drugs ...